3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Glioblastoma
4
Solitary Fibrous Tumor, Pleural
3
Mesothelioma, Malignant
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Lung Neoplasms
2
Gliosarcoma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uveal Melanoma
1
Thyroid cancer, Hurthle cell
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hypertension
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
cediranib
×
Clear all
No trials found.